Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Sarissa Capital Management

BioCentury | Feb 9, 2024
Finance

Venture report: Scion’s launch, rounds for Neurona, Attralus and Basking

New firm, affiliated with NYC-based Petrichor, will put $310M fund toward company creation
BioCentury | Jul 20, 2023
Management Tracks

Tessier-Lavigne exonerated by review panel, steps down as Stanford president

Plus: Amarin hires Holt to pull off restructuring, turnaround and updates from Accession and Greenleaf
BioCentury | Apr 18, 2023
Management Tracks

Vagelos retiring as chair of Regeneron

Plus: Berg named interim CEO of Amarin, and updates from ITM, Biohaven and Foresee
BioCentury | Mar 31, 2023
Management Tracks

Amarin CEO Mikhail resigns, Kostas named chair

Plus: BioCryst appoints Hutson chair and updates from Flare, Mytide and TScan
BioCentury | Mar 7, 2023
Management Tracks

Seven Amarin directors resign after Sarissa proxy win

Plus: Ocugen expands Quan Vu’s role to CBO and CFO, and updates from BPGbio and MediWound
BioCentury | Jul 22, 2022
Management Tracks

ASCO, AACR praise Biden’s pick of Monica Bertagnolli to lead NCI 

Plus Simeonidis becomes co-CEO and co-CIO at Ally Bridge, and Corinne Le Goff to lead Celsion
BioCentury | Sep 9, 2021
Deals

Sept. 8 Quick Takes: Logos leads crossovers in Attralus’ $116M round

Denner, Bauer join board of pan-amyloid removal company, plus: Resilience-Moderna, Exscientia-Gates  
BioCentury | Aug 24, 2018
Finance

Navigating the Hot Topics landscape

BioCentury announces “Hot Topics” NewsMakers Luncheon Panel
Items per page:
1 - 10 of 42